Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Shandong Weigao Group Medical Polymer Co ( (HK:1066) ).
Shandong Weigao Group Medical Polymer Co has made an overseas regulatory announcement in accordance with the disclosure requirements of the Hong Kong Stock Exchange. The announcement, published on the Shanghai Stock Exchange’s website, is part of the company’s compliance with relevant Chinese regulations, highlighting its commitment to transparency and adherence to market rules.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Co is a joint stock limited company based in the People’s Republic of China, specializing in medical polymer products. The company is involved in the medical industry, focusing on the production and distribution of medical devices and equipment.
Average Trading Volume: 15,690,708
Technical Sentiment Signal: Sell
Current Market Cap: HK$25.33B
See more data about 1066 stock on TipRanks’ Stock Analysis page.